U.S. House Passes Authorization to Include Shrimp in Seafood Import Monitoring Program
Mar 22, 2018 20:51 pm UTC| Business
BILOXI, Miss., March 22, 2018 -- "We are very pleased that today, the US House of Representatives passed the FY2018 Omnibus Appropriations Bill to fund the federal government through September 30, 2018," said Dr. David...
Pacific Biosciences Prevails in Patent Eligibility Ruling Against Oxford Nanopore
Mar 22, 2018 20:35 pm UTC| Business
MENLO PARK, Calif., March 22, 2018 -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leader in long-read, high-resolution sequencing, today announced that Judge Leonard P. Stark of the U.S. District Court...
Overstock.com Announces 2018 Annual Meeting of Stockholders
Mar 22, 2018 20:33 pm UTC| Business
SALT LAKE CITY, March 22, 2018 -- Overstock.com, Inc. (NASDAQ:OSTK) announced today that its 2018 annual meeting of stockholders will be held at 1:00 p.m. (Mountain Time) on May 9, 2018 at its corporate offices located...
CORRECTING and REPLACING - American Electric Technologies to Report Fourth Quarter 2017 Results
Mar 22, 2018 20:33 pm UTC| Business
HOUSTON, March 22, 2018 -- In a release issued earlier today under the same headline, American Electric Technologies, Inc. (Nasdaq:AETI) provided an incorrect date for its conference call. The conference call will take...
California Public Utilities Commission Approves Revised Cost of Capital Proposed Decision
Mar 22, 2018 20:30 pm UTC| Business
SAN JOSE, Calif., March 22, 2018 -- Today, the California Public Utilities Commission adopted a revised proposed decision in the cost of capital proceeding for California Water Service (Cal Water) and three other water...
S&P Upgrades Barrick to BBB with Stable Outlook
Mar 22, 2018 20:30 pm UTC| Business
All amounts expressed in U.S. dollars TORONTO, March 22, 2018 -- Barrick Gold Corporation (NYSE:ABX) (TSX:ABX) (Barrick or the “Company”) today reported that SP Global Ratings (“SP”) has upgraded Barrick’s long-term...
Atara Biotherapeutics to Participate in Three Upcoming Immuno-Oncology Conferences
Mar 22, 2018 20:30 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., March 22, 2018 -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a leading off-the-shelf T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral...